AI
JAZZ icon

AXS Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

AXS Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$761K Sell
3,160
-112
-3% -$24.5K 0.22% 75
2026
Q1 		$619K Sell
3,272
-112
-3% -$19.6K 0.25% 78
2025
Q4 		$575K Sell
3,384
-112
-3% -$17.2K 0.2% 96
2025
Q3 		$461K Sell
3,496
-112
-3% -$13.4K 0.15% 100
2025
Q2 		$383K Sell
3,608
-1,792
-33% -$195K 0.16% 123
2025
Q1 		$670K Buy
+5,400
New +$704K 0.19% 167
2024
Q1 		– Sell
-1,490
Closed -$183K – 363
2023
Q4 		$183K Buy
+1,490
New +$186K 0.04% 291

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

AXS Investments's JAZZ Position: Q2 2026 in Review

AXS Investments reduced its Jazz Pharmaceuticals (JAZZ) stake by 3.4% in Q2 2026, selling an estimated $24.5K and leaving 3,160 shares worth $761K. The position accounts for 0.22% of the portfolio, ranked #75.

AXS Investments first reported a position in JAZZ in Q4 2023 and has held it in 7 quarters since. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • AXS Investments held 3,160 shares of Jazz Pharmaceuticals worth $761K as of Q2 2026.
  • AXS Investments sold 112 Jazz Pharmaceuticals shares in Q2 2026, an estimated $24.5K.
  • Jazz Pharmaceuticals made up 0.22% of AXS Investments's portfolio in Q2 2026, its #75 holding.
  • AXS Investments first reported a position in Jazz Pharmaceuticals in Q4 2023 and has held it in 7 quarters since.
  • 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on AXS Investments's 13F filing for Q2 2026, filed 10 Aug 2026.